Corcept Therapeutics (CORT) Current Taxes (2017 - 2018)
Corcept Therapeutics (CORT) posted Current Taxes of $1.6 million for Q3 2018, up 130.42% sequentially from $687000.0 in Q2 2018.
Powered by 
Analysis
Corcept Therapeutics (CORT) Current Taxes (2017 - 2018) Analysis & Trends
Corcept Therapeutics has reported Current Taxes for 2 years, with the latest figure at $1.6 million in Q3 2018.
- Quarterly Current Taxes changed N/A year-over-year to $1.6 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $1.6 million (changed N/A YoY) and the FY2017 annual result came in at $66000.0, changed N/A from the prior year.
- Current Taxes rose to $1.6 million in Q3 2018 per CORT's latest filing, from $687000.0 in the prior quarter.
- Over five years, Current Taxes peaked at $1.6 million in Q3 2018 and troughed at $66000.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Corcept Therapeutics | 11.76 Bn | 11.46 Bn | 252.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 1.58 Mn |
| Jun 30, 2018 | 687,000.00 |
| Mar 31, 2018 | 728,000.00 |
| Dec 31, 2017 | 66,000.00 |